4D Molecular Therapeutics Inc - ESG Rating & Company Profile powered by AI
Scroll down to the end of this page for potential risks for 4D Molecular Therapeutics Inc based on sector, location and marketcap. Comprehensive ESG assessment of 4D Molecular Therapeutics Inc are accessed by signing up for free. This page contains a questions and answers section for 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 3.2 and governance score of 4.8.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | 4D Molecular Therapeutics Inc | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does 4D Molecular Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid 4D Molecular Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas 4D Molecular Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs 4D Molecular Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes 4D Molecular Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes 4D Molecular Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for 4D Molecular Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; Benitec; CRF; Roche; CFF; and AstraZeneca. The company was founded in 2013 and is headquartered in Emeryville, California.